Telotristat ethyl: proof of principle and the first oral agent in the management of well-differentiated metastatic neuroendocrine tumor and carcinoid syndrome diarrhea.
about
Telotristat ethyl: proof of principle and the first oral agent in the management of well-differentiated metastatic neuroendocrine tumor and carcinoid syndrome diarrhea.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Telotristat ethyl: proof of pr ...... d carcinoid syndrome diarrhea.
@en
Telotristat ethyl: proof of pr ...... d carcinoid syndrome diarrhea.
@nl
type
label
Telotristat ethyl: proof of pr ...... d carcinoid syndrome diarrhea.
@en
Telotristat ethyl: proof of pr ...... d carcinoid syndrome diarrhea.
@nl
prefLabel
Telotristat ethyl: proof of pr ...... d carcinoid syndrome diarrhea.
@en
Telotristat ethyl: proof of pr ...... d carcinoid syndrome diarrhea.
@nl
P2860
P1476
Telotristat ethyl: proof of pr ...... d carcinoid syndrome diarrhea.
@en
P2093
Muhammad Masab
Muhammad Wasif Saif
P2860
P2888
P304
P356
10.1007/S00280-017-3462-Y
P577
2017-10-19T00:00:00Z